Background Recurrence of papillary thyroid cancer is not uncommon, but incorporating
clinicopathologic parameters to predict recurrence is suboptimal. The aim of this study was …

Context Thyroid cancer recurrence is associated with increased mortality and adverse
outcomes. Recurrence risk is currently predicted using clinical tools, often restaging patients …

Background Although well-differentiated papillary thyroid cancer may remain indolent,
lymph node metastases and the recurrence rates are approximately 50% and 20 …

The papillary thyroid carcinoma (PTC) usually shows an excellent prognosis. But some
patients suffer recurrence after treatment. Recent progress in RNA sequencing (RNA-Seq) …

BACKGROUND: A better understanding of the molecular mechanisms involved in papillary
thyroid cancer (PTC)-associated adverse outcome is needed to manage these patients …

BACKGROUND: Genetic screening studies suggest that genetic changes underlie
progression from well differentiated to anaplastic thyroid cancers. The aim of this study is to …

Thyroid cancer is increasing in incidence. Although often indolent and highly curable
neoplasms, they may recur, metastasize, or become resistant to radio-iodine therapy …

As the importance of personalized therapeutics in aggressive papillary thyroid cancer (PTC)
increases, accurate risk stratification is required. To develop a novel prognostic scoring …

Background Differentiated thyroid cancer (DTC) generally has a favorable outcome, but
some patients develop local recurrence and/or distant metastases and ultimately die of their …

Several lines of evidence suggest that follicular cell-derived thyroid cancers represent a
continuum of disease that progresses from the highly curable well-differentiated thyroid …